BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Hydroxyurea

An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

300+ PubMed studies analyzed · 20 RCTs · Evidence Score: 51.4

Research Domains

Hydroxyurea has been studied across 13 research domains including 🔬 Oncology, ✨ Skin & Hair, 🫁 Liver & Detox, 😴 Sleep, 💊 Pain. The primary research focus is 🔬 Oncology with 8% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Hydroxyurea, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Sulfadoxine
2 shared targets
Tinidazole
2 shared targets
Tetracycline
2 shared targets
Deslanoside
3 shared targets
Clofarabine
4 shared targets
Doxycycline
2 shared targets
Puromycin
2 shared targets
Gemcitabine
2 shared targets
Flecainide
2 shared targets
Topotecan
3 shared targets
Loading evidence profile...

This evidence profile for Hydroxyurea is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.